Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Galenica to commercialize Roche's Mircera in U.S.

May 29, 2015

Jinarc approved in Europe for autosomal dominant polycystic kidney disease

May 28, 2015

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

May 27, 2015

Daiichi Sankyo develops phosphate transporter inhibitors

May 22, 2015

Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder

May 18, 2015

Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function

May 18, 2015

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

May 8, 2015

Tenapanor fails to significantly reduce albuminuria in patients with CKD and type 2 diabetes

May 6, 2015

Recruitment initiated in phase II trial of CicloMulsion for acute kidney injury

April 28, 2015

Merck & Co. presents novel MR antagonists

April 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...